160 related articles for article (PubMed ID: 24122835)
1. Amplification and over-expression of MAP3K3 gene in human breast cancer promotes formation and survival of breast cancer cells.
Fan Y; Ge N; Wang X; Sun W; Mao R; Bu W; Creighton CJ; Zheng P; Vasudevan S; An L; Yang J; Zhao YJ; Zhang H; Li XN; Rao PH; Leung E; Lu YJ; Gray JW; Schiff R; Hilsenbeck SG; Osborne CK; Yang J; Zhang H
J Pathol; 2014 Jan; 232(1):75-86. PubMed ID: 24122835
[TBL] [Abstract][Full Text] [Related]
2. RNAi silencing of the MEKK3 gene promotes TRAIL-induced apoptosis in MCF-7 cells and suppresses the transcriptional activity of NF-κB.
Guo SY; Liu SG; Liu L; Zhou XJ; Gu Y
Oncol Rep; 2012 Feb; 27(2):441-6. PubMed ID: 22020406
[TBL] [Abstract][Full Text] [Related]
3. MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer.
He Y; Wang L; Liu W; Zhong J; Bai S; Wang Z; Thomas DG; Lin J; Reddy RM; Ramnath N; Carrott PW; Lynch WR; Orringer MB; Chang AC; Beer DG; Chen G
Sci Rep; 2015 Jun; 5():11471. PubMed ID: 26088427
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of MAP3K3 promotes tumour growth through activation of the NF-κB signalling pathway in ovarian carcinoma.
Zhang Y; Wang SS; Tao L; Pang LJ; Zou H; Liang WH; Liu Z; Guo SL; Jiang JF; Zhang WJ; Jia W; Li F
Sci Rep; 2019 Jun; 9(1):8401. PubMed ID: 31182739
[TBL] [Abstract][Full Text] [Related]
5. MiR-194 regulates nasopharyngeal carcinoma progression by modulating MAP3K3 expression.
Yin W; Shi L; Mao Y
FEBS Open Bio; 2019 Jan; 9(1):43-52. PubMed ID: 30652073
[TBL] [Abstract][Full Text] [Related]
6. MiroRNA-188 Acts as Tumor Suppressor in Non-Small-Cell Lung Cancer by Targeting MAP3K3.
Zhao L; Ni X; Zhao L; Zhang Y; Jin D; Yin W; Wang D; Zhang W
Mol Pharm; 2018 Apr; 15(4):1682-1689. PubMed ID: 29528232
[TBL] [Abstract][Full Text] [Related]
7. The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.
Zhang N; Wang X; Huo Q; Li X; Wang H; Schneider P; Hu G; Yang Q
J Biol Chem; 2013 Mar; 288(13):9396-407. PubMed ID: 23408429
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458.
Gui D; Cao H
In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):24-33. PubMed ID: 31950433
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of MEKK3 confers resistance to apoptosis through activation of NFkappaB.
Samanta AK; Huang HJ; Bast RC; Liao WS
J Biol Chem; 2004 Feb; 279(9):7576-83. PubMed ID: 14662759
[TBL] [Abstract][Full Text] [Related]
10. Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
Reinhardt A; Liu H; Ma Y; Zhou Y; Zang C; Habbel JP; Possinger K; Eucker J
Anticancer Res; 2018 May; 38(5):2669-2682. PubMed ID: 29715087
[TBL] [Abstract][Full Text] [Related]
11. Amplification of fibroblast growth factor receptor-1 in breast cancer and the effects of brivanib alaninate.
Shiang CY; Qi Y; Wang B; Lazar V; Wang J; Fraser Symmans W; Hortobagyi GN; Andre F; Pusztai L
Breast Cancer Res Treat; 2010 Oct; 123(3):747-55. PubMed ID: 20024612
[TBL] [Abstract][Full Text] [Related]
12. Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells.
Wang Q; Maloof P; Wang H; Fenig E; Stein D; Nichols G; Denny TN; Yahalom J; Wieder R
Exp Cell Res; 1998 Jan; 238(1):177-87. PubMed ID: 9457070
[TBL] [Abstract][Full Text] [Related]
13. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
Singh TR; Shankar S; Chen X; Asim M; Srivastava RK
Cancer Res; 2003 Sep; 63(17):5390-400. PubMed ID: 14500373
[TBL] [Abstract][Full Text] [Related]
14. Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray.
Weldon CB; Scandurro AB; Rolfe KW; Clayton JL; Elliott S; Butler NN; Melnik LI; Alam J; McLachlan JA; Jaffe BM; Beckman BS; Burow ME
Surgery; 2002 Aug; 132(2):293-301. PubMed ID: 12219026
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Keane MM; Ettenberg SA; Nau MM; Russell EK; Lipkowitz S
Cancer Res; 1999 Feb; 59(3):734-41. PubMed ID: 9973225
[TBL] [Abstract][Full Text] [Related]
16. The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer.
Zhou Z; Liu R; Chen C
Int J Cancer; 2012 Apr; 130(7):1504-10. PubMed ID: 21480222
[TBL] [Abstract][Full Text] [Related]
17. Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells.
Yanochko GM; Eckhart W
Breast Cancer Res; 2006; 8(2):R18. PubMed ID: 16584539
[TBL] [Abstract][Full Text] [Related]
18. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
19. Essential role of c-Jun-NH2-terminal kinase on synergy induction of apoptosis by TRAIL plus ADM in ADM resistant MCF-7/ADM cells.
Li F; Meng L; Xing H; Zhou J; Wang S; Huang L; Xu G; Zhu H; Lu Y; Ma D
Apoptosis; 2006 Jul; 11(7):1239-46. PubMed ID: 16703262
[TBL] [Abstract][Full Text] [Related]
20. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
